Begin typing your search above and press return to search.
proflie-avatar
Login
exit_to_app
Peoples priority is livelihood issues
access_time 12 April 2024 4:30 AM GMT
The survival challenge before the CPM
access_time 10 April 2024 5:05 AM GMT
NATO
access_time 9 April 2024 4:00 AM GMT
Genocide failing in its goal
access_time 8 April 2024 4:13 AM GMT
DEEP READ
Schools breeding hatred
access_time 14 Sep 2023 10:37 AM GMT
Ukraine
access_time 16 Aug 2023 5:46 AM GMT
Ramadan: Its essence and lessons
access_time 13 March 2024 9:24 AM GMT
exit_to_app
Homechevron_rightIndiachevron_rightTruenat test kit gets...

Truenat test kit gets DCGI nod for Nipah virus testing

text_fields
bookmark_border
Truenat test kit gets DCGI nod for Nipah virus testing
cancel

New Delhi: The Drugs Controller General of India (DCGI) has granted emergency use authorization (EAU) to Truenat, a real-time PCR platform, to conduct Nipah virus tests, the company said on Wednesday.

Manufactured by Goa-based Molbio Diagnostics, this is the first kit in India to receive regulatory approval to conduct tests for Nipah.

Truenat is an indigenous portable, battery-operated, Internet of Things-enabled RT-PCR platform developed and manufactured in India. It can test for nearly 30 diseases, and results take less than an hour.

Truenat is already playing a critical role in the management of infectious diseases such as TB, Covid-19, dengue, chikungunya, hepatitis, and HPV in the country.

"Covid-19 has brought out the importance of early and accurate testing for better disease management. Truenat is the first platform to be authorised by the DGCI for Nipah virus testing. We are proud to support our country in fighting Nipah Virus," Molbio Diagnostics Director and CEO Sriram Natarajan said in a statement.

Nipah virus is an emerging zoonotic disease that causes severe disease in humans. Signs and symptoms range from asymptomatic to acute respiratory infection and fatal encephalitis.

Last week, it claimed the life of a 12-year-old boy in Kerala amid a Covid surge.

Previously, India has seen three outbreaks: Siliguri in 2001 and Nadia in 2007 (both West Bengal), and Kozhikode and Malappuram in Kerala in 2018.

Molbio first started R&D work on the Truenat test for the Nipah virus in 2018 in collaboration with the National Institute of Virology, Pune.

"The ability to quickly deploy the platform to the point of need and the rapid testing capability makes it a powerful tool in diagnosis and containment of the Nipah Virus. This collaboration with NIV allows us to react quickly in times of need such as emergencies," Molbio Diagnostics Director and CTO, Dr Chandrasekhar Nair, said in the statement.

Truenat is also approved by the World Health Organisation for TB diagnosis and approved by the ICMR for TB, Covid-19 and other diseases.

Show Full Article
TAGS:DCGINipah VirusTruenatnipah test
Next Story